Center, 1983 - Google Patents
Identification of rat mast cell-derived chemoattractant factors for lymphocytesCenter, 1983
View PDF- Document ID
- 13454381046450521680
- Author
- Center D
- Publication year
- Publication venue
- Journal of Allergy and Clinical Immunology
External Links
Snippet
Rat peritoneal and pleural mast cells have been demonstrated to release their granule- associated mediators, including chemotactic factors for eosinophilic polymorphonuclear leukocytes, after challenge with rabbit anti-rat F (ab′) 2 antisera in vitro. The presence of …
- 210000004698 Lymphocytes 0 title abstract description 48
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sarfati et al. | Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia | |
| Lett-Brown et al. | Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor | |
| Krueger et al. | Inflammatory and immune cell function in psoriasis: II. Monocyte function, lymphokine production | |
| Kay et al. | Chemotaxis of human basophil leucocytes | |
| Togawa et al. | Characterization of lymphocyte-activating factor (LAF) produced by human mononuclear cells: biochemical relationship of high and low molecular weight forms of LAF | |
| Djeu et al. | Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. | |
| Rachelefsky et al. | Defective T cell function in atopic dermatitis | |
| Koopman et al. | Association of a low molecular weight helper factor (s) with thymocyte proliferative activity | |
| Kretschmer et al. | Inhibition of human monocyte locomotion by products of axenically grown E. histolytica | |
| Wright et al. | Modulation of the inflammatory response by products released from human polymorphonuclear leukocytes during phagocytosis: generation and inactivation of the chemotactic factor C5a | |
| Snyderman et al. | Chemotaxis of macrophages | |
| Fuks et al. | Reversal of cell surface abnormalities of T lymphocytes in Hodgkin's disease after in vitro incubation in fetal sera | |
| Akiyama et al. | Differential ability of human blood monocyte subsets to release various cytokines | |
| Center | Identification of rat mast cell-derived chemoattractant factors for lymphocytes | |
| Center et al. | Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand. | |
| El-Arini et al. | Differentiation of thymus-derived cells from precursors in mouse bone marrow | |
| Wieder et al. | Cell-free translation of a biologically active, antigen-specific suppressor T cell factor. | |
| Silva et al. | Differential correlation between interleukin patterns in disseminated and chronic human paracoccidioidomycosis | |
| Rocklin et al. | Activation of antigen-specific suppressor cells in human schistosomiasis mansoni by fractions of soluble egg antigens nonadherent to Con A sepharose. | |
| US20110177036A1 (en) | Whole blood cultures comprising stimulated immune cells, and use thereof as medicaments | |
| KR20010053290A (en) | Chemotaxis-inhibiting protein of Staphylococcus (CHIPS) and its use | |
| Wadee et al. | The effects of a soluble factor released by sensitized mononuclear cells incubated with S. haematobium ova on eosinophil migration. | |
| Pancre et al. | IgE-dependent killing of Brugia malayi microfilariae by human platelets and its modulation by T cell products | |
| Uchida et al. | Clinical studies on cell-mediated immunity in patients with malignant disease: II. Suppressor cells in patients with cancer | |
| Duncan et al. | The null T cell in pig blood is not an NK cell. |